Evidence map›Paper›PMID 36418380›Full record

ArticleCommunications medicine2022

Comparison of artificial intelligence and human-based prediction and stratification of the risk of long-term kidney allograft failure.

Gillian Divard, Marc Raynaud, Vasishta S Tatapudi, Basmah Abdalla, Elodie Bailly, Maureen Assayag, Yannick Binois, Raphael Cohen, Huanxi Zhang, Camillo Ulloa and 8 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Communications medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03652402 completednot on this map

The EUropean TRAnsplantation and INnovation Consortium for Risk Stratification in Kidney Transplant Patients

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2018 to 2021Enrolled558ConditionsKidney Transplant Rejection, Kidney Transplantation, Risk Stratification, PrognosisArmskidney transplantation
NCT07600541 recruitingnot on this mapstarted 2026, after this paper: background citation

Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine

TypeobservationalSponsorParis Translational Research Center for Organ TransplantationRan2026 to 2026Enrolled1,000ConditionsKidney Transplant
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Data-driven decision making in patient management: a systematic review.BMC medical informatics and decision making · 2025
    Pooled it
  2. AI-enabled clinical trials.Nature reviews bioengineering · 2026
    Article
  3. Article
  4. Review
  5. Shaping the Future of AI in Organ Transplantation: Position Paper of the European Society for Organ Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 5 countries.

Gillian Divard *Université de Paris Cité, INSERM U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France.
Marc Raynaud *Université de Paris Cité, INSERM U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France.
Vasishta S TatapudiNYU Langone Transplant Institute, NYU Langone Health, New York, NY, USA.
Basmah AbdallaDepartment of Medicine, Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-0143-6581
Elodie BaillyUniversité de Paris Cité, INSERM U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France.
Maureen AssayagKidney Transplant Department, Bicêtre Hospital, Assistance Publique - Hôpitaux de Paris, Kremlin-Bicêtre, France.
Yannick BinoisMedical Intensive Care Unit, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Raphael CohenDepartment of Physiology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
Huanxi ZhangThe First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Camillo UlloaClinica Alemana de Santiago, Santiago, Chile.
Kamila LinharesUniversidade Federal de Sao Paulo, Hospital do Rim, Escola Paulista de Medicina, Sao Paulo, Brazil.
Helio S TedescoUniversidade Federal de Sao Paulo, Hospital do Rim, Escola Paulista de Medicina, Sao Paulo, Brazil.
Christophe LegendreUniversité de Paris Cité, INSERM U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France.
Xavier JouvenUniversité de Paris Cité, INSERM U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France.
Robert A MontgomeryNYU Langone Transplant Institute, NYU Langone Health, New York, NY, USA.
Carmen LefaucheurUniversité de Paris Cité, INSERM U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France.
Olivier Aubert *Université de Paris Cité, INSERM U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France.
Alexandre Loupy *Université de Paris Cité, INSERM U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France. alexandre.loupy@inserm.fr.ORCID http://orcid.org/0000-0003-3388-7747
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRHospital do Rim e Hipertensão · BRMiami Transplant Institute · USClínica Alemana · CLSun Yat-sen University · CNUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical decisions are mainly driven by the ability of physicians to apply risk stratification to patients. However, this task is difficult as it requires complex integration of numerous parameters and is impacted by patient heterogeneity. We sought to evaluate the ability of transplant physicians to predict the risk of long-term allograft failure and compare them to a validated artificial intelligence (AI) prediction algorithm.

methodsWe randomly selected 400 kidney transplant recipients from a qualified dataset of 4000 patients. For each patient, 44 features routinely collected during the first-year post-transplant were compiled in an electronic health record (EHR). We enrolled 9 transplant physicians at various career stages. At 1-year post-transplant, they blindly predicted the long-term graft survival with probabilities for each patient. Their predictions were compared with those of a validated prediction system (iBox). We assessed the determinants of each physician's prediction using a random forest survival model.

resultsAmong the 400 patients included, 84 graft failures occurred at 7 years post-evaluation. The iBox system demonstrates the best predictive performance with a discrimination of 0.79 and a median calibration error of 5.79%, while physicians tend to overestimate the risk of graft failure. Physicians' risk predictions show wide heterogeneity with a moderate intraclass correlation of 0.58. The determinants of physicians' prediction are disparate, with poor agreement regardless of their clinical experience.

conclusionsThis study shows the overall limited performance and consistency of physicians to predict the risk of long-term graft failure, demonstrated by the superior performances of the iBox. This study supports the use of a companion tool to help physicians in their prognostic judgement and decision-making in clinical care.

Identifiers

PMID36418380
PMCPMC9684574
OpenAlexW4309891368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.